Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

2.0K
The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
2.0K
Gastric Motility01:16

Gastric Motility

3.6K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.6K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.4K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

3.5K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.5K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

1.5K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism of action of Trolox on duodenal contractility.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2014
Same author

Involvement of neuronal nitric oxide synthase (nNOS) in the regulation of migrating motor complex (MMC) in sheep.

Veterinary journal (London, England : 1997)·2011
Same author

Extracellular signal-regulated kinase (ERK) is involved in LPS-induced disturbances in intestinal motility.

Neurogastroenterology and motility·2010
Same author

Role of potassium channels in rabbit intestinal motility disorders induced by 2, 2'-azobis (2-amidinopropane) dihydrochloride (AAPH).

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2010
Same author

Inhibition of p38 MAPK improves intestinal disturbances and oxidative stress induced in a rabbit endotoxemia model.

Neurogastroenterology and motility·2009
Same author

Melatonin and Trolox ameliorate duodenal LPS-induced disturbances and oxidative stress.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2009

Related Experiment Video

Updated: Mar 1, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

14.8K

5-hydroxytryptamine and the gastrointestinal migrating motor complex.

M A Plaza1

  • 1Department of Pharmacology and Physiology, Veterinary Faculty, Zaragoza, Spain. aplaza@posta.unizar.es

Current Opinion in Investigational Drugs (London, England : 2000)
|September 22, 2001
PubMed
Summary
This summary is machine-generated.

The migrating motor complex (MMC), a key gut motility pattern, is regulated by 5-hydroxytryptamine (5-HT). Understanding 5-HT receptors is crucial for treating gastrointestinal disorders where MMC is disturbed.

More Related Videos

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines
12:00

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

10.9K
Gastrointestinal Motility Monitor GIMM
08:15

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

31.6K

Related Experiment Videos

Last Updated: Mar 1, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

14.8K
Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines
12:00

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

10.9K
Gastrointestinal Motility Monitor GIMM
08:15

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

31.6K

Area of Science:

  • Gastroenterology and Physiology
  • Neurogastroenterology
  • Pharmacology

Background:

  • The migrating motor complex (MMC) represents a fundamental cyclic motility pattern in the gastrointestinal tract during interdigestive periods.
  • 5-hydroxytryptamine (5-HT), also known as serotonin, is increasingly recognized as a critical regulator of MMC.
  • Disruptions in MMC patterns are associated with various gastrointestinal disorders, highlighting the clinical relevance of its regulatory mechanisms.

Purpose of the Study:

  • To review and synthesize current knowledge regarding the specific roles of 5-hydroxytryptamine receptors in the control of the migrating motor complex.
  • To elucidate the mechanisms by which 5-HT signaling influences gastrointestinal motility during fasting periods.

Main Methods:

  • Literature review of existing studies on 5-HT and MMC.
  • Analysis of research investigating the function of different 5-HT receptor subtypes in gastrointestinal motility.
  • Synthesis of data from in vivo and in vitro experimental models.

Main Results:

  • Multiple 5-HT receptor subtypes are expressed in the gastrointestinal tract and contribute to MMC regulation.
  • Specific 5-HT receptor activation or blockade can modulate MMC frequency and amplitude.
  • 5-HT's role in MMC is complex, involving interactions with the enteric nervous system and smooth muscle cells.

Conclusions:

  • 5-hydroxytryptamine receptors are essential components in the neural and muscular control of the migrating motor complex.
  • Targeting specific 5-HT receptors may offer therapeutic strategies for gastrointestinal motility disorders characterized by MMC dysfunction.
  • Further research is warranted to fully delineate the intricate signaling pathways involving 5-HT in MMC regulation.